These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 31876914)

  • 21. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
    Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck Cancer.
    Falchook AD; Green R; Knowles ME; Amdur RJ; Mendenhall W; Hayes DN; Grilley-Olson JE; Weiss J; Reeve BB; Mitchell SA; Basch EM; Chera BS
    JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):517-23. PubMed ID: 27149571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy.
    Baumann BC; Hallahan DE; Michalski JM; Perez CA; Metz JM
    Br J Cancer; 2020 Sep; 123(6):869-870. PubMed ID: 32555364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective, Randomized Study of Radiation Dose Escalation With Combined Proton-Photon Therapy for Benign Meningiomas.
    Sanford NN; Yeap BY; Larvie M; Daartz J; Munzenrider JE; Liebsch NJ; Fullerton B; Pan E; Loeffler JS; Shih HA
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):787-796. PubMed ID: 28865924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of Acute Skin Toxicities in Patients With Breast Cancer Undergoing Adjuvant Proton versus Photon Radiation Therapy: A Single Institutional Experience.
    DeCesaris CM; Rice SR; Bentzen SM; Jatczak J; Mishra MV; Nichols EM
    Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1084-1090. PubMed ID: 31028831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-Term Outcomes After Proton Beam Therapy for Sinonasal Squamous Cell Carcinoma.
    Russo AL; Adams JA; Weyman EA; Busse PM; Goldberg SI; Varvares M; Deschler DD; Lin DT; Delaney TF; Chan AW
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):368-376. PubMed ID: 27084654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of adverse effects of proton and X-ray chemoradiotherapy for esophageal cancer using an adaptive dose-volume histogram analysis.
    Makishima H; Ishikawa H; Terunuma T; Hashimoto T; Yamanashi K; Sekiguchi T; Mizumoto M; Okumura T; Sakae T; Sakurai H
    J Radiat Res; 2015 May; 56(3):568-76. PubMed ID: 25755255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of 1p/19q Codeletion and Radiation Necrosis in Adult Cranial Gliomas After Proton or Photon Therapy.
    Acharya S; Robinson CG; Michalski JM; Mullen D; DeWees TA; Campian JL; Chundury A; Bottani B; Hallahan DE; Bradley JD; Huang J
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):334-343. PubMed ID: 29534896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcomes after proton therapy, with concurrent chemotherapy, for stage II-III inoperable non-small cell lung cancer.
    Nguyen QN; Ly NB; Komaki R; Levy LB; Gomez DR; Chang JY; Allen PK; Mehran RJ; Lu C; Gillin M; Liao Z; Cox JD
    Radiother Oncol; 2015 Jun; 115(3):367-72. PubMed ID: 26028228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.
    Chun SG; Hu C; Choy H; Komaki RU; Timmerman RD; Schild SE; Bogart JA; Dobelbower MC; Bosch W; Galvin JM; Kavadi VS; Narayan S; Iyengar P; Robinson CG; Wynn RB; Raben A; Augspurger ME; MacRae RM; Paulus R; Bradley JD
    J Clin Oncol; 2017 Jan; 35(1):56-62. PubMed ID: 28034064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concurrent erlotinib and radiotherapy for chemoradiotherapy-intolerant esophageal squamous cell carcinoma patients: results of a pilot study.
    Zhai Y; Hui Z; Wang J; Zou S; Liang J; Wang X; Lv J; Chen B; Zhu H; Wang L
    Dis Esophagus; 2013 Jul; 26(5):503-9. PubMed ID: 22862289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of acute toxicity grade ≥ 3 in patients with locally advanced non-small-cell lung cancer receiving intensity modulated radiotherapy and concurrent low-dose Cisplatin.
    Uyterlinde W; Belderbos J; Baas C; van Werkhoven E; Knegjens J; Baas P; Smit A; Rikers C; van den Heuvel M
    Clin Lung Cancer; 2013 Sep; 14(5):541-8. PubMed ID: 23835165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting the Effect of Proton Beam Therapy Technology on Pulmonary Toxicities for Patients With Locally Advanced Lung Cancer Enrolled in the Proton Collaborative Group Prospective Clinical Trial.
    Valdes G; Scholey J; Nano TF; Gennatas ED; Mohindra P; Mohammed N; Zeng J; Kotecha R; Rosen LR; Chang J; Tsai HK; Urbanic JJ; Vargas CE; Yu NY; Ungar LH; Eaton E; Simone CB
    Int J Radiat Oncol Biol Phys; 2024 May; 119(1):66-77. PubMed ID: 38000701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Comparison of Patient-Reported Health-Related Quality of Life During Proton Versus Photon Chemoradiation Therapy for Esophageal Cancer.
    Garant A; Whitaker TJ; Spears GM; Routman DM; Harmsen WS; Wilhite TJ; Ashman JB; Sio TT; Rule WG; Neben Wittich MA; Martenson JA; Tryggestad EJ; Yoon HH; Blackmon S; Merrell KW; Haddock MG; Hallemeier CL
    Pract Radiat Oncol; 2019 Nov; 9(6):410-417. PubMed ID: 31310815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial.
    Nestle U; Schimek-Jasch T; Kremp S; Schaefer-Schuler A; Mix M; Küsters A; Tosch M; Hehr T; Eschmann SM; Bultel YP; Hass P; Fleckenstein J; Thieme A; Stockinger M; Dieckmann K; Miederer M; Holl G; Rischke HC; Gkika E; Adebahr S; König J; Grosu AL;
    Lancet Oncol; 2020 Apr; 21(4):581-592. PubMed ID: 32171429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study.
    Sun XS; Tao Y; Le Tourneau C; Pointreau Y; Sire C; Kaminsky MC; Coutte A; Alfonsi M; Boisselier P; Martin L; Miroir J; Ramee JF; Delord JP; Clatot F; Rolland F; Villa J; Magne N; Elicin O; Gherga E; Nguyen F; Lafond C; Bera G; Calugaru V; Geoffrois L; Chauffert B; Zubel A; Zanna C; Brienza S; Crompton P; Rouits E; Gollmer K; Szyldergemajn S; Bourhis J
    Lancet Oncol; 2020 Sep; 21(9):1173-1187. PubMed ID: 32758455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of Predictive Scoring System for 90-Day Mortality Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Completed Concurrent Chemoradiotherapy.
    Lin KC; Chen TM; Yuan KS; Wu ATH; Wu SY
    JAMA Netw Open; 2020 Mar; 3(3):e1920671. PubMed ID: 32215631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. External beam radiation dose escalation for high grade glioma.
    Khan L; Soliman H; Sahgal A; Perry J; Xu W; Tsao MN
    Cochrane Database Syst Rev; 2016 Aug; (8):CD011475. PubMed ID: 27541334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in Survival With Surgery and Postoperative Radiotherapy Compared With Definitive Chemoradiotherapy for Oral Cavity Cancer: A National Cancer Database Analysis.
    Spiotto MT; Jefferson G; Wenig B; Markiewicz M; Weichselbaum RR; Koshy M
    JAMA Otolaryngol Head Neck Surg; 2017 Jul; 143(7):691-699. PubMed ID: 28426848
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.